Clearline Capital LP Elanco Animal Health Inc Transaction History
Clearline Capital LP
- $2.27 Billion
- Q3 2024
A detailed history of Clearline Capital LP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Clearline Capital LP holds 51,933 shares of ELAN stock, worth $624,753. This represents 0.03% of its overall portfolio holdings.
Number of Shares
51,933
Previous 37,133
39.86%
Holding current value
$624,753
Previous $535,000
42.43%
% of portfolio
0.03%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ELAN
# of Institutions
443Shares Held
474MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$632 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$589 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$280 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$256 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.7B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...